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Abstract
Background: Chronic non-specific low-back pain (LBP) is one of the most common and expensive musculoskeletal
disorders in industrialized countries. Similar to other countries in the world, LBP is a common health and
socioeconomic problem in Iran. One of the most widely used modalities in the field of physiotherapy for treating
LBP is therapeutic ultrasound. Despite its common use, there is still inconclusive evidence to support its
effectiveness in this group of patients. This randomised trial will evaluate the effectiveness of continuous
ultrasound in addition to exercise therapy in patients with chronic LBP.
Methods and design: A total of 46 patients, between the ages 18 and 65 years old who have had LBP for more
than three months will be recruited from university hospitals. Participants will be randomized to receive continuous
ultrasound plus exercise therapy or placebo ultrasound plus exercise therapy. These groups will be treated for 10
sessions during a period of 4 weeks. Primary outcome measures will be functional disability and pain intensity.
Lumbar flexion and extension range of motion, as well as changes in electromyography muscle fatigue indices, will
be measured as secondary outcomes. All outcome measures will be measured at baseline, after completion of the
treatment sessions, and after one month.
Discussion: The results of this trial will help to provide some evidence regarding the use of continuous ultrasound
in chronic LBP patients. This should lead to a more evidence-based approach to clinical decision making regarding
the use of ultrasound for LBP.
Trial registration: Netherlands Trial Register (NTR): NTR2251
Background
Low back pain (LBP) is the most frequent self-reported
type of musculoskeletal pain, is often recurrent, and has
important socio-economic consequences. Estimates of
the prevalence of LBP and are as high as 33% for point
prevalence, 65% for 1-year prevalence, and 84% for life-
time prevalence [1].
Similar to other countries in the world, LBP is a com-
mon health and socioeconomic problem in Iran. In a
cross-sectional study in one of the largest car-manufac-
turing companies in Iran, the 1-year prevalence of self-
reported LBP was 21% (20% males and 27% females).
The prevalence rate of absence due to LBP was 5% per
annum [2]. As part of a World Health Organization
study, LBP was detected in 15.4% of the population
under survey in Tehran (urban area) [3] and in 23.4% of
the population in rural areas in Iran [4].
LBP is defined as pain and discomfort in the lumbosa-
cral region, below the twelfth rib and above the gluteal
crease. According to the recommended diagnostic triage,
three types of back pain can be defined: 1) non-specific
low back pain; 2) back pain with nerve root symptoms;
and 3) back pain resulting from serious pathology (e.g.
malignancy, fracture, ankylosing spondylitis, infection).
Non-specific LBP, in which there is no recognized patho-
anatomic cause, is usually a benign condition but without
appropriate management can develop into chronic LBP.
Using the traditional classification system, LBP is also
categorized according to its duration from onset, as
acute (<6 weeks), sub-acute (6 weeks - 12 weeks), and
* Correspondence: s_ebadi@razi.tums.ac.ir
1Rehabilitation Faculty, Tehran University of Medical Sciences, Iran
Full list of author information is available at the end of the article
Ebadi et al. BMC Musculoskeletal Disorders 2011, 12:59
http://www.biomedcentral.com/1471-2474/12/59
© 2011 Ebadi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
chronic (>12 weeks) [5,6]. Chronic LBP remains a com-
mon problem that many practitioners have to deal with
in primary care, secondary care, and occupational health
care.
The main objective of treatment for chronic LBP is for
the patient to return to their desired level of activities and
participation, as well as the prevention of chronic com-
plaints and recurrences [7]. Many treatments are com-
monly used for LBP such as medication, physiotherapy,
and surgery. Many of these interventions have been evalu-
ated in randomized controlled trials and systematic
reviews. Evidence shows that the effectiveness of some of
the interventions is supported (e.g. exercise), while it
shows that other interventions are not effective for LBP
(e.g. laser therapy and traction) [8-10]. The number of
randomized trials varies widely across interventions, from
61 for exercise therapy to 19 on back school and 4 on trans-
cutaneous electrical nerve stimulation (TENS) [9,11,12].
Therapeutic ultrasound is used frequently in the treat-
ment of LBP by many physiotherapists around the
world and after more than 60 years of clinical use, there
is still great controversy over its usefulness [13-16].
According to two recent clinical guidelines, the UK
NICE guideline http://guidance.nice.org.uk/CG88 and
the COST B13 European guideline for the management
of LBP [5], there is no evidence regarding the benefit of
using electrotherapy modalities such as interferential,
laser, TENS, and ultrasound even though these modal-
ities are commonly used in physiotherapy practice. The
guidelines and recent systematic reviews [17] of thera-
peutic ultrasound have highlighted a need for further
research to investigate the true effect of these modalities
in the context of well conducted randomized controlled
trials. As the application of ultrasound may have adverse
effects for patients with LBP (e.g. because of the trans-
mission of thermal energy), it is important to know
whether the benefits outweigh the risks of this com-
monly used intervention.
This study will aim to investigate the effects of contin-
uous ultrasound with pre-defined doses, in comparison
with sham ultrasound, delivered in combination with a
semi-supervised exercise program on pain intensity and
function in patients with chronic LBP. This study has




A single blind randomized controlled trial in which par-
ticipants with chronic LBP will be randomized to one of
two treatment groups:
• Continuous ultrasound + semi-supervised exercise
therapy
• Sham ultrasound + semi-supervised exercise
therapy
Study population
Patients aged between 18 and 65 years who present with
chronic LBP will be recruited for this study.
Inclusion and exclusion criteria
Patients with LBP who have pain for more than 3 months
will be eligible. Patients with nerve root symptoms,
underlying systematic or visceral disease, and specific
conditions such as neoplasm, fractures, spondylolysthesis,
spondylolysis, spinal stenosis, ankylosing spondylitis, pre-
vious low back surgery, and pregnancy will be excluded.
The researcher will also ask potential participants if they
take any medication for specific psychological problems
in which case they will be excluded.
Recruitment procedures
Recruitment will take place in two steps: firstly, ortho-
paedic surgeons from three university hospitals in
Tehran, Iran will identify potentially eligible patients
and refer them to the research centre at the Rehabilita-
tion Faculty of Tehran University of Medical Sciences.
Secondly, the researcher will conduct another screening
for inclusion and exclusion criteria and make the final
decision regarding eligibility. If eligible, the patient will
be provided with oral and written information about the
study. After having signed a consent form, patients will
be randomized to one of the two treatment groups.
Randomization
Opaque, sealed envelopes will be prepared to the total
number of patients using a computer generated rando-
mization schedule, with half of the envelopes being allo-
cated to each group ensuring equal number of subjects
in each group.
The list and the envelopes will be prepared by a statis-
tician who is not involved with the study prior to com-
mencement of the trial to ensure concealment of patient
allocation.
Sample size
According to the data of a randomised pilot study which
involved 10 patients, the effect size based on the Func-
tional Rating Scale (FRI) was calculated to be 1.83. Since
the number of patients in the pilot study was few, we cal-
culated the sample size for the current study using an
effect size of 0.8. Considering the results of our previous
article [18] and the results obtained from the pilot study
we expect ultrasound to be more effective and have cho-
sen a one-sided test to calculate the sample size. Assuming
alpha and power to be 0.05 and 0.8, in a one-tailed test the
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total sample size needed is 42 (21 patients in each group).
Accounting for 10% drop-out, the total number of patients
required is 46 (23 patients in each group).
Interventions
Subjects in each group will receive 10 sessions of treat-
ment, each around 20 minutes, during a period of
4 weeks. All treatment, ultrasound delivery, and exercise
prescription will be provided by the same licensed and
experienced physiotherapist who will be instructed by
the researcher about the study protocol.
Ultrasound application
Therapeutic ultrasound is proposed to deliver energy to
deep tissue sites through ultrasonic waves, to produce
increases in tissue temperature or non-thermal physiolo-
gic changes [19]. Unlike ultrasound for medical imaging
(which transmits ultrasonic waves and processes a
returning echo to generate an image), therapeutic ultra-
sound is a one-way energy delivery which utilises a crys-
tal sound head to transmit acoustic waves at 1 or 3 MHz
and at amplitude densities between 0.1 and 3 W/cm2
[16,19]. Ultrasonic energy causes soft tissue molecules to
vibrate from exposure to the acoustic wave. This
increased molecular motion generates frictional heat,
thus increasing tissue temperature. Referred to as ultra-
sound’s “thermal effects”, this heating is proposed to
increase collagen extensibility, increase nerve conduction
velocity, alter local vascular perfusion, increase enzymatic
activity, alter contractile activity of skeletal muscle, and
increase nociceptive threshold [16,19].
While recent systematic reviews of therapeutic ultra-
sound have failed to identify a dose-response relation-
ship [17], dosage ranges from 0.5 W/cm2 to 3 W/cm2
(spatial average temporal average) have been advocated
to minimise adverse effects [20]. Recently published ran-
domised controlled trials which have reported significant
benefits of therapeutic ultrasound over placebo ultra-
sound have used dosages of 1 W/cm2 to 1.5 W/cm2
[18,21].
In the current study, the patients will receive continu-
ous ultrasound using Enraf Nonius Sonoplus 434 oper-
ated at a frequency of 1 MHz and intensity of 1.5 W/
cm2 (spatial average temporal average). Slow circular
movements will be applied by the transducer head over
the paravertebral low back region. The duration of ultra-
sound application will be estimated for each patient
using Grey’s formula [22]:
Total treatment time =planned local exposure time×
(
tissue area/effective radiating area
)
For this study, the average local exposure time is
planned to be one minute and the effective radiating
area of the transducer head is 5 cm2. For a patient with
an area of low back pain of 40 cm2, for example, the
required total treatment time is: 1 min × (40 cm2 /5
cm2) = 8 minutes.
Placebo ultrasound
Patients in the placebo ultrasound group will receive the
same duration of ultrasound with the apparatus
switched on (so that patients will see the lights flashing
on the machine) but without any current output. In this
way, patients will be blinded for the ultrasound treat-
ment. Success of this blinding, and consequently poten-
tial bias, will be evaluated by asking patients at the end
of the intervention period if they think that they have
received verum or placebo ultrasound.
Exercise therapy
Exercise therapy is defined as “a series of specific move-
ments with the aim of training or developing the body
by a routine practice or as physical training to promote
good physical health” [9]. Exercise therapy appears to be
slightly effective for decreasing pain and improving
function in adults with chronic LBP [9]. Studies on ther-
apeutic exercises often fail to provide details on the spe-
cific exercise techniques used and the exact exercise
protocol that was prescribed or followed (e.g. dose, tim-
ing, intensity) [23]. In our study both groups will receive
pamphlets in which all the exercises that are going to be
taught during the treatment period will be available in
combination with pictures.
This semi-supervised exercise program will start with
stretching routines for the lower limbs as well as the
lower back. Then strengthening exercises for abdom-
inal muscles and paravertebral muscles of the low back
will be added to each session according to the phy-
siotherapist’s judgment of the patient’s condition. Evi-
dence suggest that lumbar extensor strengthening
exercise administered alone or with co-interventions is
more effective than no treatment and most passive
modalities for improving pain, disability, and other
patient-reported outcomes in chronic LBP [23]. The
rationale behind choosing this exercise plan was
because access to exercise facilities may be limited and
patients can easily learn and practice the prescribed
exercises at home.
Patients will be asked to perform the exercises on a
daily basis (every day). To encourage aerobic activity,
patients will be advised to stay active during the day
and try to walk for at least 15 minutes before exercising,
which can also act as a warm up. In each session the
patient will be asked to perform the exercises in front of
the therapist to check for correctness. The therapist will
then decide whether the patient should be progressed
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by making the exercises more difficult or increasing the
number of repetitions. After completion of treatment
sessions patients will be advised to continue staying
active and will visit the clinic once a week to check
their exercises and continue progression until the fol-
low-up measuring session.
Avoiding co-interventions
Patients will be requested not to commence new pain
medications during the intervention period (from the
beginning of treatment sessions until the end of follow-
up period) and not to participate in any other exercise
or treatment program. Co-interventions, including use
of regular pain medication, will be measured during fol-
low-up to evaluate potential bias.
Outcome measures
Patient’s specifications such as age, sex, body mass
index, and pain history will be recorded in a demo-
graphic questionnaire at the baseline assessment. All
primary and secondary outcome measures will be mea-
sured by the researcher at baseline, the final treatment
session (after 4 weeks), and at a follow-up measurement
after 3 months.
Primary outcome measures will be
• Functional disability due to LBP measured by the
Functional Rating Index.
• Pain measured on a visual analogue scale (VAS)
Functional Rating Index
The Functional Rating Index (FRI) is an instrument spe-
cifically designed to quantitatively measure the subjec-
tive perception of function and pain in the spinal area
in a clinical environment. It has shown to also have
satisfactory reliability and validity [24,25]. The FRI is a
10-item questionnaire consisting of 5-point Likert scales.
The patient ranks his or her perceived disability at the
present time by selecting one of the five points of the
scale (0 - “no pain or full ability to function"; 4 - “worst
possible pain and/or unable to perform this function at
all”). The total score is obtained by summing the item
scores and expressed as percentage from zero (no dis-
ability) to 100% (severe disability).
Visual analogue scale
A visual analogue scale (VAS) is a commonly used,
quick, reliable, and valid means to measure pain inten-
sity in a variety of clinical contexts. This scale is a 100-
mm horizontal line, where 0 mm indicates ‘’No pain’’
and 100 mm indicates ‘’Unbearable pain.’’
Secondary outcome measures will be
• Paravertebral muscle fatigue during a Biering-Sor-
ensen test using surface electromyography and ana-
lysing the changes in fatigue indices after the
treatment.
• Lumbar flexion and extension range of motion
using the modified-modified Schober test
Reduced endurance capacity of back extensor muscles
has been associated with chronic LBP [26,27]. Electro-
myography (EMG) spectral indices and their shift
towards lower frequencies have been validated as tools
to objectively monitor local lumbar back extensor fati-
gue in both healthy and LBP populations [28,29]. In this
study we use EMG indices to evaluate whether the addi-
tion of ultrasound to exercise therapy will result in
improved endurance outcomes.
Biering-Sorensen test
The Biering-Sorensen test is a method for evaluating para-
vertebral muscle fatigue which was first introduced by
Hansen and then modified by Biering-Sorensen [26]. In
this test the subject will be asked to keep an unsupported
prone horizontal position as long as possible, while their
legs and hips are fixed to a bed. We will use a two part
hydraulic bed in which the section under the upper body
can be brought down slowly by pressing on an electronic
button. The examiner will then ask the patient to keep
his/her horizontal position. During the test, EMG activity
of iliocostalis lumborum, multifidus and gluteus maximus
will be recorded bilaterally using an 8 channel surface
EMG recorder (DATA Log Biometrics Ltd). Surface EMG
activity of the dominant side biceps femoris will also be
recorded. The eighth channel will be connected to a digital
goniometer. The end point of holding time would be when
the patient fails from the horizontal position by more than
5 degrees as recorded by a digital goniometer.
Recording surface EMG activity
Usually, assessment of fatigability in the Biering-Sorensen
test is based on measuring endurance time, but this is
hampered by subjective qualities such as motivation and
tolerance to discomfort or pain. Electromyographic (EMG)
spectral index compression toward lower frequencies has
been employed to overcome this problem by measuring
objectively the back extensor fatigability in isometric
endurance contractions [30]. After shaving and cleaning
the skin, the following electrodes will be attached:
Iliocostalis lumborum and multifidus
The determination of muscle fibre orientation is based
on the recommendations of De Foa et al [31].
Gluteus maximus
At the midpoint of a line running from the inferior lat-
eral angle of the sacrum to the greater trochanter [32].
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Biceps femoris
At the midpoint of a line running between the ischial
tuberosity and the proximal head of the fibula [32].
The digital goniometer will be positioned on the lum-
bar region according to the manual instruction of the
apparatus. Surface EMG of the isometric activity of these
muscles will be recorded during holding time. Holding
time, median and mean power frequency slopes and
intercepts, as well as the slope of the standard deviation
of lumbar angle will be extracted from raw EMG using
MATLAB version 7 and analysed by SPSS, version 17.
Lumbar range of motion
Lumbar flexion and extension range of motion will be
measured according to the modified-modified Schober
(MMS) method. The MMS test has shown to produce
reliable measurements of spinal flexion and extension in
patients with LBP (Pearson’s r = 0.78 to 0.89 for flexion
and 0.69 to 0.91 for extension) compared with use of
the double inclinometer technique (Pearson’s r = 0.13 to
0.87 for flexion and 0.28 to 0.66 for extension), with less
time to obtain the measurement [33].
In this method the two posterior superior iliac spines
(PSIS) will be connected with a line on the skin and the
middle of the line (first mark) and 15 cm above (second
mark) will be marked. As the patient moves into lumbar
flexion or extension, the distance between the two
marks is measured and subtracted from the 15 cm dis-
tance in the neutral position [33].
Data collection and analysis
An intention-to-treat analysis will be performed. In the
case of dropouts and withdrawals, the last recorded
values for the main outcome measures will be used in the
analysis. We will check if the two groups are similar for
the most important demographic characteristics and all
outcome measures at baseline. In case of finding any dif-
ferences we will adjust for them in a regression analysis.
Between-group differences in the change of scores of all
outcome measures will be analysed using the Statistical
Package for the Social Sciences (SPSS) version 17. We
will consider whether the data meet parametric or non-
parametric conditions. If parametric, ANOVA, indepen-
dent and paired t-tests will be used and in case of non-
parametric conditions we will use Kruskal-Wallis, Mann-
Whitney and Wilcoxon signed-rank tests. All analyses
will be performed blinded for treatment allocation.
Discussion
The fact that there are more than 20 types of treatment
for chronic LBP, each of which has multiple subcategories,
is a testament that no single approach has yet been able to
demonstrate its definitive superiority [34]. For example,
exercise therapy is one promising treatment option, but
there is still no consensus upon which kind is the most
effective [9]. This situation makes it very challenging for
clinicians, policy makers, insurers, and patients to make
decisions regarding which treatment is the most appropri-
ate for chronic LBP.
Despite the widespread use of therapeutic ultrasound
as one of the most popular and commonly used modal-
ities in the field of physiotherapy for LBP patients, there
is still limited evidence of its effectiveness. Only a few
RCTs have investigated the effect of ultrasound in treat-
ing patients with chronic LBP; often with varying meth-
odology qualities and very small sample sizes, and have
not been able to provide evidence regarding its
usefulness.
The RCT we have described will evaluate the effective-
ness of therapeutic ultrasound in addition to exercise
therapy in patients with chronic LBP. The advantages of
this study would be comparing the ultrasound with pla-
cebo ultrasound, which would clarify the value of adding
ultrasound to a semi-supervised exercise program. Lim-
ited possibilities for double blinding can be a potential
limitation to this study. Meanwhile we will evaluate
potential bias by asking the patients whether they think
they received real or sham ultrasound on the last treat-
ment session. Recruiting a sufficient number of patients
will be one of the most challenging elements of this
study since it will be conducted without substantial
funding.
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